SCHEMBL28042347

SCHEMBL28042347

CCc1c(N)nc(-n2cc(-c3ccccc3)cn2)nc1N

nearest known ligand 0.45

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
EGLN1 Q9GZT9 4/20 0.45
PDE10A Q9Y233 5/20 0.44
L3MBTL1 Q9Y468 2/20 0.43
KDM4E B2RXH2 2/20 0.43
MAPT P10636 1/20 0.43
MAPK1 P28482 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
DHFR P00374 1/20 0.40
HEXA P06865 1/20 0.40
HEXB P07686 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.37
ADORA2A P29274 1/20 0.37
TLR8 Q9NR97 2/20 0.37
USP7 Q93009 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28042545 0.77 PDE10A (0.68) PDE10AMAPTDHFRADORA2A
SCHEMBL15904056 0.76 PDE10A (0.57) EGLN1PDE10AL3MBTL1KDM4EMAPT
SCHEMBL2553742 0.69 ADORA2A (0.58) L3MBTL1KDM4EMAPTMAPK1NPSR1
SCHEMBL12629776 0.69 MAPT (0.45) EGLN1PDE10AL3MBTL1KDM4EMAPT
SCHEMBL1207015 0.67 L3MBTL1 (0.42) EGLN1L3MBTL1KDM4ESMN1; SMN2
SCHEMBL515503 0.67 GAA (0.59) L3MBTL1KDM4EMAPTSMN1; SMN2
SCHEMBL12235674 0.67 GRM4 (0.49) L3MBTL1KDM4EMAPTMAPK1NPSR1
SCHEMBL17736002 0.66 GAA (0.57) L3MBTL1MAPTSMN1; SMN2
SCHEMBL513941 0.66 GAA (0.52) L3MBTL1MAPT
SCHEMBL15904189 0.65 PDE10A (0.72) PDE10AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105008346-A Novel pyrimidine derivatives as phosphodiesterase 10(PDE-10) inhibitors PALOBIOFARMA SL 2015-10-28 CN claimed
CN-105008346-A Novel pyrimidine derivatives as phosphodiesterase 10(PDE-10) inhibitors PALOBIOFARMA SL 2015-10-28 CN disclosed